$ZYNE Zynerba Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zynerba Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Zynerba Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Zynerba Pharmaceuticals, Inc. for free.
IRS Number: 260389433
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ZYNE
Company Address: 80 W. LANCASTER AVENUE SUITE 300 DEVON 19333
Phone number: 610-263-0163
Former name: AllTranz, Inc.
Former name: Zynerba Pharmeceuticals, Inc., date of change: 2014-10-03
Market Capitalization: $186.92M
Prev close: $18.47
Average Daily Volume: 339,039
Days Low: $18.09
Year Low: $4.64
Year High: $23.07
Zynerba Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 3.58 | 78,000 | 279,240 | 78,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 52,000 | 0 | 72,718 | 20.7 K to 72.7 K (+250.99 %) |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Option Exercise | A | 3.58 | 161,867 | 579,484 | 161,867 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | ANIDO ARMANDO | Chairman & Chief Ex ... | Grant | A | 0.00 | 107,911 | 0 | 460,423 | 352.5 K to 460.4 K (+30.61 %) |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Option Exercise | A | 3.58 | 110,000 | 393,800 | 110,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Sebree Terri B | President | Grant | A | 0.00 | 75,000 | 0 | 261,146 | 186.1 K to 261.1 K (+40.29 %) |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial & Bu ... | Option Exercise | A | 3.58 | 55,000 | 196,900 | 55,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Rosenberger Brian | VP, Commercial & Bu ... | Grant | A | 0.00 | 37,000 | 0 | 37,000 | 0 to 37 K |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Option Exercise | A | 3.58 | 55,000 | 196,900 | 55,000 | |
| Jan 25 2021 | ZYNE | Zynerba Pharmaceut ... | Hanlon Suzanne M. | Sec, VP & General C ... | Grant | A | 0.00 | 37,000 | 0 | 80,693 | 43.7 K to 80.7 K (+84.68 %) |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | COOPER WARREN D | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | FEDERICI WILLIAM J | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | Stephenson Pamela | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 |
View all Zynerba Pharmaceuticals, Inc. insider transactions.